HighTower Advisors’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$434K Buy
104,652
+13,112
+14% +$53.2K ﹤0.01% 2844
2025
Q4
$591K Sell
91,540
-9,498
-9% -$59.2K ﹤0.01% 2490
2025
Q3
$565K Buy
101,038
+1,425
+1% +$6.16K ﹤0.01% 2517
2025
Q2
$330K Sell
99,613
-9,050
-8% -$26K ﹤0.01% 2843
2025
Q1
$315K Buy
108,663
+29,027
+36% +$87.9K ﹤0.01% 2823
2024
Q4
$284K Sell
79,636
-28,377
-26% -$131K ﹤0.01% 2927
2024
Q3
$537K Sell
108,013
-200
-0.2% -$778 ﹤0.01% 2350
2024
Q2
$282K Buy
+108,213
New +$361K ﹤0.01% 2760
2024
Q1
Sell
-130,805
Closed -$265K 3625
2023
Q4
$265K Buy
130,805
+500
+0.4% +$884 ﹤0.01% 2795
2023
Q3
$199K Hold
130,305
﹤0.01% 2917
2023
Q2
$216K Hold
130,305
﹤0.01% 2806
2023
Q1
$148K Hold
130,305
﹤0.01% 2845
2022
Q4
$117K Hold
130,305
﹤0.01% 2918
2022
Q3
$152K Buy
+130,305
New +$147K ﹤0.01% 2667
2022
Q2
Sell
-130,305
Closed -$340K 3241
2022
Q1
$340K Buy
130,305
+1,500
+1% +$4.38K ﹤0.01% 2429
2021
Q4
$501K Buy
128,805
+2,000
+2% +$10K ﹤0.01% 2158
2021
Q3
$553K Hold
126,805
﹤0.01% 1995
2021
Q2
$504K Buy
126,805
+58,188
+85% +$232K ﹤0.01% 2042
2021
Q1
$357K Buy
+68,617
New +$365K ﹤0.01% 2172

Other funds holding AQST